Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?Drugpatentwatch skyrizi biologic patent analysis?How does iron rich food intake impact lipitor's efficacy?Cost promethazine price?Patent expiry trametinib?
See the DrugPatentWatch profile for tezspire
Tezspire (tezepelumab-ekko) was launched in the United States in March 2022 after U.S. approval in late 2021. [1]
Yes. The FDA approved tezepelumab in December 2021, and it reached the market the following year (with launch reported in March 2022). [1]
DrugPatentWatch.com tracks key dates tied to approvals and market entry, including the March 2022 launch. [1] Sources: [1] https://www.drugpatentwatch.com/uk/drugs/tezspire
Other Questions About Tezspire :